IP Library › Patent Application 11169322
Patent Application
App. No. 11/169,322

Intracorporeal occlusive device and method

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/169,322
Abstract

An intracorporeal space filling device and a delivery system and method of using the device is disclosed. The space filling device is preferably configured for percutaneous delivery from a peripheral conduit of a patient. The space filling device has an elongated tubular or interconnected bead structure which may have a transmutable material disposed within it. The transmutable material can be altered from a non-rigid state to a rigid state by the application of various types of energy or by other suitable means. The space filling device can be positioned by a delivery system and detached from the delivery system after desired positioning is achieved.

Claims (8)

1 . A method of occluding an intracorporeal void, comprising:

(a) positioning the distal end of a microcatheter such that a distal port in the distal end is directed to the cavity of the intracorporeal void;

(b) distally advancing an intracorporeal space filling device comprising:

an elongate tubular shell which has a first port disposed at a first end and a second port disposed at a second end and an inner lumen disposed within the shell in fluid communication with the first port and second port; and

a transmutable material disposed within the inner lumen of the shell that is transmutable from a non-rigid state to a substantially rigid state within the patient's body,

(c) deploying the space filling device into the void

(d) transmuting the transmutable material from a non-rigid state to a substantially rigid state;

(e) detaching the space filling device from the delivery system by activation of a detachment mechanism after the space filling device has been positioned with the intracorporeal void.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2017
From: MICROTRANSFORM, INC.
To: MARKS, MICHAEL P.
Reel/Frame 042393/0134 →